INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT

The present invention is related to biotechnology, particularly to the field of human health. It provides new vaccine compositions that comprise as active principle a system that contains the recombinant human EGF, or peptides thereof, and a carrier protein or peptide, bound to a nucleus constituted...

Full description

Saved in:
Bibliographic Details
Main Authors García Artalejo, Judey Aymed, González Ruiz, Gustavo, Luzardo Lorenzo, Maria del Carmen, Santo Tomás Pompa, Julio Felipe, Echeverría Luna, Yerandy, Ruiz Castro, Elaine, León Monzón, Kalet, González Martínez, David Alejandro, López Matilla, Lien, González Palomo, Adys, Bordallo León, Fernando, Sánchez Ramírez, Belinda, Cruz Rodríguez, Mabel
Format Patent
LanguageEnglish
Published 20.07.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is related to biotechnology, particularly to the field of human health. It provides new vaccine compositions that comprise as active principle a system that contains the recombinant human EGF, or peptides thereof, and a carrier protein or peptide, bound to a nucleus constituted by inorganic nanoparticles, with nanometric or submicrometric scale dimensions. These vaccine compositions are useful for the chronic treatment of cancer and have as advantages that their administration does not result in the appearance of adverse effects at the injection site and that they do not accumulate in the body.
Bibliography:Application Number: US202117928806